Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells. [electronic resource] by
- Toutirais, Olivier
- Cabillic, Florian
- Le Friec, Gaëlle
- Salot, Samuel
- Loyer, Pascal
- Le Gallo, Matthieu
- Desille, Mireille
- de La Pintière, Cécile Thomas
- Daniel, Pascale
- Bouet, Françoise
- Catros, Véronique
Producer: 20090709
In:
European journal of immunology vol. 39
Availability: No items available.
|
|
5.
|
Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy use. [electronic resource] by
- Bouet-Toussaint, Françoise
- Patard, Jean-Jacques
- Gervais, Alban
- Genetet, Noëlle
- de la Pintière, Cécile Thomas
- Rioux-Leclercq, Nathalie
- Toutirais, Olivier
- Thirouard, Anne-Sophie
- Ramée, Marie-Paule
- Catros-Quemener, Véronique
Producer: 20031202
In:
Cancer immunology, immunotherapy : CII vol. 52
Availability: No items available.
|
|
6.
|
Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients. [electronic resource] by
- Cabillic, Florian
- Toutirais, Olivier
- Lavoué, Vincent
- de La Pintière, Cécile Thomas
- Daniel, Pascale
- Rioux-Leclerc, Nathalie
- Turlin, Bruno
- Mönkkönen, Hannu
- Mönkkönen, Jukka
- Boudjema, Karim
- Catros, Véronique
- Bouet-Toussaint, Françoise
Producer: 20100921
In:
Cancer immunology, immunotherapy : CII vol. 59
Availability: No items available.
|
|
7.
|
Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: implications for immunotherapy. [electronic resource] by
- Lavoué, Vincent
- Cabillic, Florian
- Toutirais, Olivier
- Thedrez, Aurélie
- Dessarthe, Benoît
- de La Pintière, Cécile Thomas
- Daniel, Pascale
- Foucher, Fabrice
- Bauville, Estelle
- Henno, Sébastien
- Burtin, Florence
- Bansard, Jean-Yves
- Levêque, Jean
- Catros, Véronique
- Bouet-Toussaint, Françoise
Producer: 20120831
In:
International journal of cancer vol. 131
Availability: No items available.
|
|
8.
|
HLA-A*0201-restricted CEA-derived peptide CAP1 is not a suitable target for T-cell-based immunotherapy. [electronic resource] by
- Fauquembergue, Emilie
- Toutirais, Olivier
- Tougeron, David
- Drouet, Aurélie
- Le Gallo, Matthieu
- Desille, Mireille
- Cabillic, Florian
- de La Pintière, Cécile Thomas
- Iero, Manuela
- Rivoltini, Licia
- Baert-Desurmont, Stéphanie
- Leprince, Jérôme
- Vaudry, Hubert
- Sesboué, Richard
- Frébourg, Thierry
- Latouche, Jean-Baptiste
- Catros, Véronique
Producer: 20100916
In:
Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 33
Availability: No items available.
|